CIP Merchant Capital makes its second investment – CIP Merchant Capital has announced an investment in Orthofix International NV, a global medical device corporation focused on musculoskeletal healing products and value-added services traded on the Nasdaq Global Select Market. The company has bought, in aggregate, 85,000 common stock in Orthofix for a total consideration of approximately US$5 million.
The investment constitutes the company’s second investment following its investment in Coro Energy Plc announced on 22 January 2018.
About Orthofix
Orthofix International is a diversified, global medical device company focused on improving patients’ lives by providing superior reconstruction and regenerative orthopedic and spine solutions to physicians worldwide.
Headquartered in Lewisville, TX, the company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Its products are distributed in more than 50 countries around the world via Orthofix sales representatives, stocking distributors and subsidiaries.
Founded in Verona, Italy in 1980, Orthofix has approximately 900 employees around the world who are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. Many of our innovative product offerings were cultivated through affiliations with surgeons and premiere health care organizations.
Orthofix collaborates on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation (MTF), the Orthopedic Research and Education Foundation and the Texas Scottish Rite Hospital for Children.
[QD comment: CIP Merchant Capital gave itself until March 2019 to get fully invested]
CIP : CIP Merchant Capital makes its second investment